Cargando…

New Developments in Gastric Neuroendocrine Neoplasms

PURPOSE OF REVIEW: Gastric neuroendocrine neoplasms (g-NENs) are a rare type of stomach cancer. The three main subtypes have different pathogeneses, biological behaviours and clinical characteristics, so they require different management strategies. This article will provide an overview of g-NENs an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Exarchou, Klaire, Stephens, Nathan A., Moore, Andrew R., Howes, Nathan R., Pritchard, D. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Neuroendocrine Neoplasms (NS Reed, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831276/ https://www.ncbi.nlm.nih.gov/pubmed/35059996 http://dx.doi.org/10.1007/s11912-021-01175-y

Ejemplares similares

New Directions in Imaging Neuroendocrine Neoplasms
por: Refardt, Julie, et al.
Publicado: (2021)

Update on Histological Reporting Changes in Neuroendocrine Neoplasms
por: Bräutigam, Konstantin, et al.
Publicado: (2021)

The Role of Patient Support Groups in Neuroendocrine Neoplasms
por: Kolarova, Teodora, et al.
Publicado: (2021)

Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
por: Cope, Jack, et al.
Publicado: (2022)

What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
por: Ratnayake, Gowri M., et al.
Publicado: (2022)

How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
por: Niederle, Bruno, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
por: Minczeles, N.S., et al.
Publicado: (2021)

Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms
por: Trikalinos, Nikolaos A., et al.
Publicado: (2022)

Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms
por: Bourdeleau, Pauline, et al.
Publicado: (2023)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Pregnancy and Cancer: the INCIP Project
por: Maggen, Charlotte, et al.
Publicado: (2020)

Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter
por: Exarchou, Klaire, et al.
Publicado: (2022)

New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms
por: Fortunati, Emilia, et al.
Publicado: (2022)

What Is the Best Preoperative Imaging for Endometrial Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2016)

Prevention Strategies in Endometrial Carcinoma
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018)

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
por: Wortman, Bastiaan G., et al.
Publicado: (2019)

What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2019)

Fertility-Sparing and Less Radical Surgery for Cervical Cancer
por: Batman, Samantha H., et al.
Publicado: (2022)

Future therapeutic strategies in the treatment of extrapulmonary neuroendocrine carcinoma: a review
por: Robinson, Matthew D., et al.
Publicado: (2023)

A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors
por: Donadio, Mauro D., et al.
Publicado: (2023)

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
por: Perrier, Marine, et al.
Publicado: (2023)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Diagnostic value of whole-mount crypt analysis of ileal biopsy specimens for the patients with familial small intestinal neuroendocrine tumors
por: Sei, Yoshitatsu, et al.
Publicado: (2023)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
por: Rico, Karen, et al.
Publicado: (2021)

The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter study
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

New Developments in the Treatment of Neuroendocrine Tumours – RADIANT-4, NETTER-1 and Telotristat Etiprate
por: Sbardella, Emilia, et al.
Publicado: (2016)

Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019)

Discussion: Gut Neuroendocrine Disease
por: Ahlman, Håkan
Publicado: (1992)

Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
por: Lloyd, Katie A., et al.
Publicado: (2020)

Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
por: Gleitz, Hélène F.E., et al.
Publicado: (2019)

Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
por: Mollazadegan, Kazhan, et al.
Publicado: (2021)

Biliary tract neoplasms: diagnosis and staging
por: Gore, Richard M., et al.
Publicado: (2007)

Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues
por: Brascia, Debora, et al.
Publicado: (2022)

Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019)

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
por: Barbui, Tiziano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9s4n9icp5m8vghmc96gnubfgfo